Bioengineered protein shows preliminary promise as new therapy for hemophilia
Sunday, October 23, 2011 - 12:30
in Biology & Nature
A genetically engineered clotting factor that controlled hemophilia in an animal study offers a novel potential treatment for human hemophilia and a broad range of other bleeding problems.